Korean Journal of Otorhinolaryngology-Head and Neck Surgery

Korean Society of Otolaryngology-Head and Neck Surgery (대한이비인후과학회)
권호 표지

Immunotherapy for Allergic Rhinitis: Current and Future

알레르기비염에서 면역요법의 현재와 미래

Rhee, Chae-Seo
이재서

  • Published : 2005.11.05
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Ray NF, Baraniuk JN, Thamer M, Rinehart CS, Gergen PJ, Kaliner M, et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996. including the contributations of related airway illness. J Allergy Clinlmmunol 1999:103:401-7
  2. Ross RN. The costs of allergic rhinitis. Am J Manag Care 1996:2:285-90
  3. Togias A. Rhinitis and asthma: Evidence for respiratory system integration. J Allergy Clin Immunol 2003:111:1171-83 https://doi.org/10.1067/mai.2003.1592
  4. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999:341:468-75 https://doi.org/10.1056/NEJM199908123410702
  5. Secrist H, DeKruyff RH, Umetsu DT. Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med 1995:181:1081-9 https://doi.org/10.1084/jem.181.3.1081
  6. Reider N, Reider D, Ebner S, Holzmann S, Herold M, Fritsch P, et al. Dendritic cells contribute to the development of atopy by an insufficieny in IL-12 production. J Allergy Clin Immunol 2002:109:89-95 https://doi.org/10.1067/mai.2002.120556
  7. Ebner C, Siemann U, Bohle B, Willheim M, Wiedermann U, Schenk S, et al. Immunological changes during specific immunotherapy of grass pollen allergy: Reduced lymphoproliferative responses to allergen and shift from TH2 to THI in T-cell clones specific for PhI p I. a major grass pollen allergen. Clin Exp Allergy 1997:27:1007-15 https://doi.org/10.1111/j.1365-2222.1997.tb01252.x
  8. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993:178:2123-30 https://doi.org/10.1084/jem.178.6.2123
  9. Till SJ, Francis IN, Nouri-Aria K, Durham SR. Mechanisms of immunotherapy. J Allergy Clin Immunol 2004:113:1025-34 https://doi.org/10.1016/j.jaci.2004.03.024
  10. Akdis CA. Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in spe-cific immunotherapy. J Clin Invest 1998:102:98-106 https://doi.org/10.1172/JCI2250
  11. Francis JN, Till SJ, Durham SR. Induction of IL-IO+CD4+CD25+ T cells hy grass pollen immunotherapy . J Allergy Clin Immunol 2003:111:1255-61 https://doi.org/10.1067/mai.2003.1570
  12. Vissers JL, van Esch BC, Hofman GA, Kapsenberg ML, Weller FR, van Oosterhout AJ. Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model . J Allergy Clin lmmunol 2004:113:1204-10 https://doi.org/10.1016/j.jaci.2004.02.041
  13. Gehlhar K. Schlaak M, Becker W, Bufe A. Monitoring allergen immunotherapy of pollen-allergic patients: The ratio of allergen-specific IgG4 to IgGI correlates with clinical outcome. Clin Exp Allergy 1999:29:497-506 https://doi.org/10.1046/j.1365-2222.1999.00525.x
  14. Lichtenstein LM, Ishizaka K, Norman PS, Sobotka AK, Hill BM. IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. J Clin Invest 1973:52:472-82 https://doi.org/10.1172/JCI107204
  15. Malbec O, Fong DC, Turner M, Tybulewicz VL, Cambier JC, Fridman WH, et al. Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation: J Immunol 1998:160:1647-58
  16. Kolbe L, Heusser CH, Kolsch E. Isotype-associated recognition of allergen epitopes and its modulation by antigen dose. Immunology 1995:84:285-9
  17. Des Roches A, Paradis L, Knani J, Hejjaoui A. Dhivert H, Chanez P, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy 1996:51:430-3
  18. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987:79:660-77 https://doi.org/10.1016/S0091-6749(87)80164-1
  19. Wood RA, Phipatanakul W, Hamilton RG, Eggleston PA. A comparison of skin prick tests, intradermal skin tests, and RASTs in the diagnosis of cat allergy. J Allergy Clin Immunol 1999:103:773-9 https://doi.org/10.1016/S0091-6749(99)70419-7
  20. Berg TL, Johansson SG. Allergy diagnosis with the radioallergosorbent test: A comparison with the results of skin and provocation tests in an unselected group of children with asthma and hay fever. J Allergy Clin Immunol 1974:54:209-21 https://doi.org/10.1016/0091-6749(74)90063-3
  21. Joint Task Force on Practice Parameters. Allergen immunotherapy: A practice parameter. American academy of allergy, asthma and immunology. American college of allergy, asthma and immunology. Ann Allergy Asthma Immunol 2003:90:1-40
  22. Rolinck-Werninghaus C, Kopp M, Liebke C, Lange J, Wahn U, Niggemann B. Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen. Int Arch Allergy Immunol 2005:136:134-41 https://doi.org/10.1159/000083320
  23. Fanta C, Bohle B, Hirt W, Siemann U, Horak F, Kraft D, et al. Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy lmmunol 1999:120:218-24 https://doi.org/10.1159/000024270
  24. Marcucci F, Sensi L, Di Cara G, Incorvaia C, Frati F. Dose dependence of immunological response to sublingual immunotherapy. Allergy 2005:60:952-6 https://doi.org/10.1111/j.1398-9995.2005.00786.x
  25. Bagnasco M, Mariani G, Passalacqua G, Motta C, Bartolomei M, Falagiani P, et al. Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j I) administered by noninjectable routes in healthy human beings. J Allergy Clin lmmunol 1997;100:122-9 https://doi.org/10.1016/S0091-6749(97)70203-3
  26. Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: A doubleblind placebocontrolled study. Allergy 2004:59:498-504 https://doi.org/10.1111/j.1398-9995.2004.00457.x
  27. Smith H, White P, Annila I, Poole J, Andre C, Frew A. Randomized controlled trial of highdose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 2004:114:831-7 https://doi.org/10.1016/j.jaci.2004.06.058
  28. Nabe T, Kubota K, Terada T, Takenaka H, Kohno S. Effect of oral immunotherapy on nasal blockage in experimental allergic rhinitis. J Pharmacol Sci 2005:98:380-7 https://doi.org/10.1254/jphs.FP0050372
  29. Georgitis JW, Clayton WF, Wypych JI, Barde SH, Reisman RE. Further evaluation of local intranasal immunotherapy with aqueous and allergoid grass extracts. J Allergy Clin Immunol 1984:74:694-700 https://doi.org/10.1016/0091-6749(84)90232-X
  30. Andri L, Senna G. Betteli C, Givanni S, Andri G. Falagiani P. Local nasal immunotherapy for Dermatophagoides-induced rhinitis: Efficacy of a powder extract. J Allergy Clin Immunol 1993:91:987-96 https://doi.org/10.1016/0091-6749(93)90211-W
  31. Passalacqua G, Altrainetti V. Mariani G, Falagiani P, Mistrello G, Braizzolara R, et al. Pharmahokinetics of radi-olabelled Par j I adminstered intranasally to allergic and healthy subjects. Clin Exp Allergy 2005:35:880-3 https://doi.org/10.1111/j.1365-2222.2005.2226.x
  32. Van Metre TE Jr. Adkinson NF Jr, Lichtenstein LM, Mardiney MR Jr, Norman PS Jr, Rosenberg GL, et al. A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever. J Allergy Clin Immunol 1980;65:288-97 https://doi.org/10.1016/0091-6749(80)90158-X
  33. Muller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998;101:747-54 https://doi.org/10.1016/S0091-6749(98)70402-6
  34. Reisinger J, Horak F, Pauli G, van Hage M, Cromwell O, Konig F, et al. Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity. J Allergy Clin Immunol 2005;116:347-54 https://doi.org/10.1016/j.jaci.2005.04.003
  35. Datta SK, Cho HJ, Takabayashi K, Horner AA, Raz E. Antigen-immunostimulatory oligonucleotide conjugates: Mechanisms and applications. Immunol Rev 2004;199:217-26 https://doi.org/10.1111/j.0105-2896.2004.00149.x
  36. Creticos PS, Lichtenstein LM. Progress in the development of new methods of immunotherapy: Potential pplication of immunostimulatory DNA-conjugated to allergens for treatment of allergic respiratory conditions. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2003;(94):304-12
  37. Adelroth E, Rak S, Haahtela T, Aasand G, Rosenhall L, Zetterstrom O, et al. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2000;106:253-9 https://doi.org/10.1067/mai.2000.108310
  38. Prussin C, Griffith DT, Boesel KM, Lin H, Foster B, Casale TB. Omalizumab treatment downregulates dendritic cell FcepsilonRI expression. J Allergy Clin Immunol 2003;112:1147-54 https://doi.org/10.1016/j.jaci.2003.10.003
  39. Lin H, Boesel KM, Griffith DT, Prussin C, Foster B, Romero FA, et al. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils. J Allergy Clin Immunol 2004;113:297-302 https://doi.org/10.1016/j.jaci.2003.11.044
  40. Plewako H, Arvidsson M, Petruson K, Oancea I, Holmberg K, Adelroth E, et al. The effect of omalizumab on nasal allergic inflammation. J Allergy Clin Immunol 2002;110:68-71 https://doi.org/10.1067/mai.2002.125488
  41. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Yang IG. lnterleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201 https://doi.org/10.1084/jem.183.1.195
  42. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. lnterleukin- 13: Central mediator of allergic asthma. Science 1998;282:2258-61 https://doi.org/10.1126/science.282.5397.2258
  43. lzuhara K, Yanagihara Y, Hamasaki N, Shirakawa T, Hopkin JM. Atopy and the human IL-4 receptor alpha chain. J Allergy Clin Immunol 2000;106:S65-S71 https://doi.org/10.1067/mai.2000.107600
  44. Hsu CH, Lin SS, Liu FL, Su WC, Yeh SD. Oral administration of a mite allergen expressed by zucchini yellow mosaic virus in cucurbit species downregulates allergen-induced airway inflammation and IgE synthesis. J Allergy Clin Immunol 2004; 113: 1079-85 https://doi.org/10.1016/j.jaci.2004.02.047